Researcher’s Profile

Lloyd E. Ratner, MD, MPH, FACS

Americas Top Doctor : 
1
Director, Renal and Pancreatic Transplantation, Department of Surgery Columbia University Medical Center, New York, NY

Targeted Intervention to Increase Living Kidney Donation (principal investigator)
Health Resources and Services Administration (HRSA) 

Abrogation of Humoral Immune Responses Utilizing Plasmapheresis/Cytogam in Positive Crossmatch and ABO Incompatible Donor/Recipient Pairs Undergoing Live Donor Renal Transplantation (principal investigator)
Medimmune

Publications: 
Boulware LE,Ratner LE,Cooper LA,LaVeist TA,Powe NR: Whole body donation for medical science: a population-based study. Clin Anat.2004 Sep 16 [Epub ahead of print].
Su LM,Ratner LE,Montgomery RA,Sinkov V,Bluebond-Langner R,Kavoussi LR: Laparoscopic live donor nephrectomy: trends in donor and recipient morbidity following three hundred and twenty-one consecutive cases. Ann Surg 2004,240(2):358-363.
Warren DS,Zachary AA,Sonnenday CJ,King KE,Cooper M,Ratner LE,Shirey RS,Haas M,Leffell MS,Montgomery RA: Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriers. Am J Trans 2004,April 4(4):561-8.
Kim FJ,Pinto P,Su LM,Jarrett TW,Ratner LE,Montgomery R,Kavoussi LR: Ipsilateral orchialgia after laparoscopic donor nephrectomy. J Endourol 2003,17(6):405-9.
Zachary AA,Montgomery RA,Ratner LE,Samaniego-Picota M,Kopchaliiska D,Leffell MS: Specific and durable elimination of antibody to donor HLA antigens in renal transplant patients. Transplantation 2003 Nov 27;76(10):1519-25.